Cargando…
Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
BACKGROUND: Recent evidence indicates that inhibition of histone deacetylase (HDAC) protects the heart against myocardial injury and stimulates endogenous angiomyogenesis. However, it remains unknown whether HDAC inhibition produces the protective effect in the diabetic heart. We sought to determine...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527099/ https://www.ncbi.nlm.nih.gov/pubmed/26245924 http://dx.doi.org/10.1186/s12933-015-0262-8 |
_version_ | 1782384524068388864 |
---|---|
author | Chen, Youfang Du, Jianfeng Zhao, Yu Tina Zhang, Ling Lv, Guorong Zhuang, Shougang Qin, Gangjian Zhao, Ting C |
author_facet | Chen, Youfang Du, Jianfeng Zhao, Yu Tina Zhang, Ling Lv, Guorong Zhuang, Shougang Qin, Gangjian Zhao, Ting C |
author_sort | Chen, Youfang |
collection | PubMed |
description | BACKGROUND: Recent evidence indicates that inhibition of histone deacetylase (HDAC) protects the heart against myocardial injury and stimulates endogenous angiomyogenesis. However, it remains unknown whether HDAC inhibition produces the protective effect in the diabetic heart. We sought to determine whether HDAC inhibition preserves cardiac performance and suppresses cardiac remodeling in diabetic cardiomyopathy. METHODS: Adult ICR mice received an intraperitoneal injection of either streptozotocin (STZ, 200 mg/kg) to establish the diabetic model or vehicle to serve as control. Once hyperglycemia was confirmed, diabetic mice received sodium butyrate (1%), a specific HDAC inhibitor, in drinking water on a daily basis to inhibit HDAC activity. Mice were randomly divided into following groups, which includes Control, Control + Sodium butyrate (NaBu), STZ and STZ + Sodium butyrate (NaBu), respectively. Myocardial function was serially assessed at 7, 14, 21 weeks following treatments. RESULTS: Echocardiography demonstrated that cardiac function was depressed in diabetic mice, but HDAC inhibition resulted in a significant functional improvement in STZ-injected mice. Likewise, HDAC inhibition attenuates cardiac hypertrophy, as evidenced by a reduced heart/tibia ratio and areas of cardiomyocytes, which is associated with reduced interstitial fibrosis and decreases in active caspase-3 and apoptotic stainings, but also increased angiogenesis in diabetic myocardium. Notably, glucose transporters (GLUT) 1 and 4 were up-regulated following HDAC inhibition, which was accompanied with increases of GLUT1 acetylation and p38 phosphorylation. Furthermore, myocardial superoxide dismutase, an important antioxidant, was elevated following HDAC inhibition in the diabetic mice. CONCLUSION: HDAC inhibition plays a critical role in improving cardiac function and suppressing myocardial remodeling in diabetic heart. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0262-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4527099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45270992015-08-07 Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice Chen, Youfang Du, Jianfeng Zhao, Yu Tina Zhang, Ling Lv, Guorong Zhuang, Shougang Qin, Gangjian Zhao, Ting C Cardiovasc Diabetol Original Investigation BACKGROUND: Recent evidence indicates that inhibition of histone deacetylase (HDAC) protects the heart against myocardial injury and stimulates endogenous angiomyogenesis. However, it remains unknown whether HDAC inhibition produces the protective effect in the diabetic heart. We sought to determine whether HDAC inhibition preserves cardiac performance and suppresses cardiac remodeling in diabetic cardiomyopathy. METHODS: Adult ICR mice received an intraperitoneal injection of either streptozotocin (STZ, 200 mg/kg) to establish the diabetic model or vehicle to serve as control. Once hyperglycemia was confirmed, diabetic mice received sodium butyrate (1%), a specific HDAC inhibitor, in drinking water on a daily basis to inhibit HDAC activity. Mice were randomly divided into following groups, which includes Control, Control + Sodium butyrate (NaBu), STZ and STZ + Sodium butyrate (NaBu), respectively. Myocardial function was serially assessed at 7, 14, 21 weeks following treatments. RESULTS: Echocardiography demonstrated that cardiac function was depressed in diabetic mice, but HDAC inhibition resulted in a significant functional improvement in STZ-injected mice. Likewise, HDAC inhibition attenuates cardiac hypertrophy, as evidenced by a reduced heart/tibia ratio and areas of cardiomyocytes, which is associated with reduced interstitial fibrosis and decreases in active caspase-3 and apoptotic stainings, but also increased angiogenesis in diabetic myocardium. Notably, glucose transporters (GLUT) 1 and 4 were up-regulated following HDAC inhibition, which was accompanied with increases of GLUT1 acetylation and p38 phosphorylation. Furthermore, myocardial superoxide dismutase, an important antioxidant, was elevated following HDAC inhibition in the diabetic mice. CONCLUSION: HDAC inhibition plays a critical role in improving cardiac function and suppressing myocardial remodeling in diabetic heart. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0262-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-07 /pmc/articles/PMC4527099/ /pubmed/26245924 http://dx.doi.org/10.1186/s12933-015-0262-8 Text en © Zhao et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Chen, Youfang Du, Jianfeng Zhao, Yu Tina Zhang, Ling Lv, Guorong Zhuang, Shougang Qin, Gangjian Zhao, Ting C Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title | Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title_full | Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title_fullStr | Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title_full_unstemmed | Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title_short | Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
title_sort | histone deacetylase (hdac) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527099/ https://www.ncbi.nlm.nih.gov/pubmed/26245924 http://dx.doi.org/10.1186/s12933-015-0262-8 |
work_keys_str_mv | AT chenyoufang histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT dujianfeng histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT zhaoyutina histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT zhangling histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT lvguorong histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT zhuangshougang histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT qingangjian histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice AT zhaotingc histonedeacetylasehdacinhibitionimprovesmyocardialfunctionandpreventscardiacremodelingindiabeticmice |